ກົມອາຫານ ແລະ ຢາ :: ກະຊວງສາທາລະນະສຸກ, ສປປລາວ ::

Items	Registration information
ID	660
No	660
Brand Name	XANILO 60 MG DDR CAPSULE
Ingredients	DEXLANSOPRAZOLE DUAL DELAYED RELEASE PELLETS EQ.TO DEXLANSOPRAZOLE 60 MG
Dosage Form	CAPSULE
Primary Packaging	ALU-ALU BLISTER
Storage
Shelf Life	24 MONTHS
Pack Size	BOX OF 3 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
Indications	• Healing of Erosive Esophagitis Xanilo is indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE) for up to eight weeks. •Maintenance of Healed Erosive Esophagitis and Relief of Heartburn Xanilo is indicated in patients 12 years of age and older to maintain healing of EE and relief of heartburn for up to six months in adults and 16 weeks in patients 12 to 17 years of age. • Treatment of Symptomatic Non-Erosive Gastroesophageal Reflux Disease Xanilois indicated in patients 12 years of age and older for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD) for four weeks.
Contraindications
Side Effects
Unit Price
EDL	NULL
Description	Hard HPMC capsule size #2, light blue opaque cap and body, containing off white to light brownish colored
Note
License Owner	EXAMED CO.,LTD
Manufacturer	MARTIN DOW LTD
Country	PAKISTAN
Import Registration No
Import Registration Date
Activity	CERTIFICATE RELEASED
Applied Date
FDD Registration No	01 I 5858/25
FDD Registration Date	23-JAN-2025
Expiry Date	22-JAN-2030